Procedure
The patient and selected donor are prepared using separate protocols; oocytes are collected, fertilised and monitored separately.
IVF and Donation Treatments · Combined Plan
Tandem IVF Treatment in Cyprus
Tandem IVF is a combined treatment approach in which IVF using the patient’s own oocytes is carried out while a suitable egg donor is prepared in parallel. The aim is to preserve the opportunity to try with the patient’s own oocytes while keeping donor oocytes available within the same plan if ovarian response is low or embryo development is insufficient.
- The patient’s own oocytes and donor oocytes are handled through separate identity and laboratory pathways.
- Donor screening, matching and consent processes are completed before treatment begins.
- The embryo group selected for transfer is determined according to patient preference and the medical plan.
Understand the treatment in 1 minute
Tandem IVF: Quick Summary
Who may be suitable?
It may be considered for patients with very low ovarian reserve or advanced reproductive age who wish to retain an attempt with their own oocytes while keeping donor oocytes as a backup option.
Laboratory stage
Embryos created from the patient’s own oocytes and donor oocytes remain in separate identity, culture and reporting pathways.
What happens next?
According to embryo development, consent and the clinical decision, one group is selected for transfer; suitable embryos from the other group may be frozen.
Key information
What Is Tandem IVF (Tandem Cycle)?
A tandem cycle is a treatment plan in which an IVF attempt using the patient’s own oocytes and an egg-donation programme are carried out in parallel or in close succession within the same treatment schedule.
In brief:
The patient and donor undergo separate ovarian stimulation; their oocytes are collected separately and fertilised within separate identity pathways. This allows embryo development from the patient’s own oocytes to be observed while a separate backup group of embryos may also be created from donor oocytes.
Tandem treatment may be considered particularly for patients who wish to make a further attempt with their own oocytes but also want to reduce the possibility of treatment ending without an embryo because of low ovarian reserve or previous poor embryo development. Preparing the donor option within the same schedule may reduce the need to start a separate donation cycle later.
This approach does not mean ‘mixing’ the patient’s oocytes with donor oocytes. Each oocyte source is labelled, fertilised, cultured and reported separately. Embryos created from the patient’s own oocytes and from donor oocytes have different genetic relationships; consent, counselling and transfer decisions should therefore be discussed in detail before treatment starts.
The term ‘tandem cycle’ is not standardised in exactly the same way in every international guideline. Clinics may use different programmes, including simultaneous stimulation, use of prepared donor oocytes, or freezing embryos for staged transfer. The actual plan proposed at Ventus IVF should be individualised according to medical suitability and applicable regulations.
- The treatment protocols for the patient and donor are separate.
- The two embryo groups are kept separate in identity and documentation.
- Transfer priority and the management of remaining embryos are determined through written consent.
- Tandem treatment does not guarantee live birth.
Treatment comparison
Difference Between a Tandem Cycle and Egg Donation
Donor oocytes may be used in both programmes; the main difference is whether treatment using the patient’s own oocytes continues within the same overall plan.
Embryos are created using donor oocytes.
While the patient undergoes endometrial preparation, suitable donor oocytes are fertilised with sperm.
- The patient may not need ovarian stimulation or oocyte collection.
- The oocyte source for the embryo is the donor.
- The programme requires donor screening, matching and consent.
IVF with the patient’s own oocytes and donation treatment are carried out in parallel.
The patient also undergoes ovarian stimulation and oocyte collection, while the donor programme is prepared separately.
- Two separate oocyte and embryo groups may be created.
- The opportunity to attempt treatment with the patient’s own oocytes is retained.
- The plan may involve more medication, procedures, coordination and cost.
Is a tandem cycle more advantageous for everyone?
No. With very low ovarian reserve, the possibility of obtaining no oocytes from the patient, together with treatment burden, cost and emotional expectations, should be considered. For some patients, direct egg donation or a separate IVF attempt using their own oocytes may be more appropriate.
Suitability assessment
Who May Be Suitable for Tandem IVF?
Suitability is not determined by AMH alone. Age, antral follicle count, previous oocyte-collection results, embryo development, pregnancy goals and the patient’s personal decision regarding donor-oocyte use are considered together.
Very low ovarian reserve
It may be considered when only a small number of follicles are expected and there is a high risk that a cycle using the patient’s own oocytes may be cancelled.
Advanced reproductive age
It may be considered for patients with age-related reduction in oocyte number and quality who still wish to attempt treatment using their own oocytes.
Repeated low response
It may be considered after previous stimulation cycles produced only a small number of oocytes or were cancelled before oocyte collection.
Poor embryo development
It may be discussed as an option for patients with repeated low fertilisation or limited blastocyst development using their own oocytes.
Patients who want to reduce delay
It may be planned for patients who wish to reduce the time required to start a separate donation cycle if treatment with their own oocytes does not produce a suitable embryo.
Patients who are ready to consider donor oocytes
It may be considered when the patient understands the genetic, consent, psychological and legal implications and makes an informed decision to accept the use of donor oocytes.
Is tandem IVF used for every patient with a low AMH?
No. Age, follicle number, previous response, pregnancy safety and the individual’s views on donor oocytes vary. In some patients, IVF using their own oocytes, a natural or modified cycle, or direct egg donation may be more appropriate.
Can tandem IVF be performed after menopause?
If there are no follicles that can respond to stimulation, the part of the programme using the patient’s own oocytes may not be possible. If the uterus and general health are suitable, an egg-donation programme may be considered separately.
Consent and embryo management
Which Embryo Is Transferred in a Tandem Cycle?
Embryo development from the patient’s own oocytes and donor oocytes is reported separately. The transfer decision is based on preferences discussed before treatment together with the actual embryo-development information available on the day of treatment.
If an embryo develops from the patient’s own oocytes
If this is the patient’s priority, transfer or freezing of a suitable embryo created from her own oocytes may be considered.
If no suitable embryo develops from the patient’s own oocytes
If prior consent has been given and a suitable embryo from donor oocytes is available, transfer from the donor group may be planned.
If embryos are available in both groups
Options such as transferring one embryo group and freezing the other are decided according to embryo number and quality, patient preference and applicable regulations.
Can an embryo from my own oocytes and an embryo from donor oocytes be transferred together?
Such an approach can create substantial uncertainty regarding genetic parentage, embryo identity and the origin of a future child. Its applicability, ethical implications and local legal framework must be assessed explicitly by the clinic and it should not be presented as a routine option.
Pre-treatment planning
What Is Done Before Starting Tandem IVF?
The patient, partner or sperm source, donor, uterus and laboratory plan are assessed through separate but connected checklists.
Ovarian reserve and previous treatments
AMH, antral follicle count, age, previous medication doses, number of oocytes collected and previous embryo outcomes are reviewed.
General health and suitability for pregnancy
The uterus, chronic conditions, medication, pregnancy-related risks and required infection screening are assessed.
Sperm and genetic assessment
Semen analysis, previous fertilisation results, carrier status and family history are considered alongside donor matching.
Donor screening and matching
Medical, infectious-disease, genetic and psychosocial assessments are completed according to applicable requirements.
Written consent and embryo plan
The preferred embryo group, storage of remaining embryos and possible scenarios are discussed in advance.
Medication and synchronisation plan
The patient’s and donor’s cycles, oocyte-collection dates and endometrial preparation are coordinated.
Psychological counselling
The use of donor gametes, genetic relationships, future disclosure to the child and family dynamics may be discussed.
Travel and logistics
A flexible schedule is prepared for travel to Cyprus, sperm provision, oocyte collection, embryo monitoring and transfer dates.
Tandem treatment step by step
How Is Tandem IVF Performed?
Two separate ovarian-stimulation and laboratory pathways are coordinated within one patient treatment roadmap.
Initial assessment and counselling
The medical, genetic, psychological and legal aspects of the tandem programme are explained.
Donor selection and screening
Health, infection and genetic assessments for the suitable donor candidate are verified.
Coordination of the cycles
The patient’s and donor’s menstrual schedules and medication start dates are planned.
Medication and ultrasound monitoring; duration may vary according to individual response.
The patient and donor are monitored separately with individual doses and appointments; their ovarian responses are independent.
Oocyte collection
Separate procedure, documentation and safety steps are used for each oocyte source.
Fertilisation and separate culture
Oocytes are fertilised with sperm; embryos from the patient and donor are monitored in separate dishes and reports.
Embryo development and decision-making
Fertilisation, day-3 and blastocyst outcomes are reviewed when deciding which embryo group to use for transfer.
Fresh transfer, freezing all suitable embryos, or transfer in a subsequent cycle.
The selected embryo is transferred; other suitable embryos may be stored according to consent and applicable regulations.
Procedure and post-transfer period
What Should You Pay Attention to During and After Tandem IVF?
Because the patient may undergo both ovarian stimulation/oocyte collection and embryo transfer, symptoms and medication requirements vary according to the stage of treatment.
After oocyte collection
Mild pain and spotting can occur. The clinic should be contacted if abdominal swelling increases, breathing becomes difficult, heavy bleeding occurs or fever develops.
Embryo decision
Development reports for embryos from the patient’s own oocytes and donor oocytes should be discussed separately, and the source of the embryo selected for transfer should be confirmed clearly.
After transfer
Progesterone and other medications are continued at the prescribed times; safe normal activity is generally advised rather than prolonged bed rest.
Possible expected symptoms
- Mild pelvic discomfort after oocyte collection
- Light spotting
- Bloating and tenderness related to medication
- No symptoms after embryo transfer
When to contact the clinic
- Rapidly increasing abdominal swelling or shortness of breath
- Heavy bleeding, fever or severe pain
- Reduced urination, persistent vomiting or fainting
- One-sided pain together with a positive pregnancy test
Treatment schedule
How Long Does Tandem IVF Take?
After donor matching and preliminary preparation have been completed, active ovarian stimulation usually lasts around two weeks; embryo culture and the transfer plan can change the total duration.
Completion of required investigations and preparation of an individual treatment schedule.
Investigations, counselling and consent.
VariableDonor matching
Screening and programme coordination.
Individual durationStimulation
Separate monitoring for the patient and donor.
Approximately 8–12 daysOocyte collection
Two separate procedures and sperm preparation.
Scheduled dayEmbryo culture
Fertilisation and blastocyst monitoring.
3–6 daysTransfer/test
Fresh transfer or later FET and beta-hCG testing.
Personalised scheduleFor international patients
How Long Do I Need to Stay in Cyprus for Tandem IVF?
Some ultrasound and blood-test monitoring may be completed where the patient lives. However, oocyte collection, sperm provision, donor coordination, embryo development and the possibility of fresh transfer can affect the dates. Flights and accommodation should be planned flexibly and confirmed with the clinic.
Explore international patient coordinationRealistic expectations
What Factors Affect Tandem IVF Outcomes?
A single success rate for tandem treatment can be misleading because embryos derived from the patient’s own oocytes and donor oocytes have different biological determinants.
Patient age and ovarian reserve
These play an important role in the number and chromosomal potential of embryos that may be obtained from the patient’s own oocytes.
Previous oocyte and embryo outcomes
Fertilisation, blastocyst development and previous transfer outcomes help shape individual expectations.
Medical suitability of the donor
Age, health, ovarian response and screening results affect the donor-oocyte group.
Sperm characteristics
Fertilisation and embryo development in both oocyte groups can be affected by sperm factors.
Embryo development
Embryos derived from the patient’s own and donor oocytes are assessed separately for fertilisation and blastocyst development.
Uterus and endometrium
Regardless of embryo source, the uterine cavity and transfer timing remain important.
Laboratory and identity safety
Traceability, culture conditions and quality control are especially important when managing two separate embryo groups.
Embryo number and transfer decision
Multiple-pregnancy risk and a single-embryo strategy are considered together with the aim of live birth.
Outcomes in a tandem programme are assessed separately
Recorded separately for the patient and donor.
Monitored separately in the two embryo groups.
Recorded according to the embryo group transferred.
The final clinical outcome of treatment.
Individual treatment scope
Tandem IVF Costs
Because a tandem cycle can involve two separate ovarian-stimulation pathways, a donor programme and extensive laboratory coordination, its cost structure may differ from standard IVF or egg donation alone.
Main factors that may affect cost
- Patient investigations and medications
- Patient oocyte-collection procedure
- Donor screening and matching
- Donor medications and monitoring
- Donor oocyte-collection procedure
- Sperm preparation and ICSI
- Culture of two separate embryo groups
- Blastocyst culture and EmbryoScope monitoring
- Embryo freezing and storage
- PGT and biopsy, when applicable
- Fresh or frozen transfer
- International patient coordination
Two separate specimen pathways
How Are Laboratory Technology and Safety Used in Tandem IVF?
In a tandem programme, laboratory safety centres on keeping the patient’s own oocytes and donor oocytes separate and traceable at every stage.
Separate records for the patient’s own and donor oocytes
Identity safety from collection through transfer or freezing
Each oocyte source is tracked with separate dishes, labels, electronic records and embryo reports. Fertilisation and blastocyst development are reported to the patient as two separate groups, and the source of the embryo loaded into the transfer catheter is confirmed at the final verification step.
- Patient, donor, sperm and embryo identities are verified using double-check procedures.
- Embryos from the patient and donor have separate culture, freezing and storage records.
- Decisions about use and storage of remaining embryos are managed through written consent.
Chip-based identification and electronic witnessing
Provides an additional verification layer intended to reduce matching errors when two oocyte sources are being managed.
ICSI and separate fertilisation
When clinically appropriate, ICSI is performed separately for each oocyte group and outcomes are reported according to the oocyte source.
Embryo development monitoring with EmbryoScope+
May support separate time-lapse monitoring of each embryo group.
AI-assisted ranking
Imaging and developmental data may provide additional information for embryo ranking; they do not determine embryo origin or pregnancy outcome and do not replace expert judgement.
CAP-accredited laboratory approach
Supports standardisation of specimen safety, documentation, staff competency, equipment and quality-control processes. Ventus IVF Center Laboratory carries CAP number 9751707.
VOC, air and gas quality
During extended embryo culture, control of temperature, pH, gases, particles and volatile organic compounds supports a stable environment.
College of American Pathologists
Ventus IVF Center Laboratory — CAP# 9751707
Accreditation reflects the laboratory quality system; it does not guarantee embryo development, pregnancy or live birth from either donor or patient oocytes.
Multidisciplinary team
Which Team Manages Tandem IVF?
A tandem cycle requires coordinated work between the physician managing the patient’s treatment, donor coordination and screening, scientific quality management and the embryology laboratory safely handling two separate embryo groups.
Treating physician
View Profile →
Treatment suitability, personalised protocol, clinical monitoring and embryo transfer planning.
View profile
Scientific Director
View Profile →
Scientific processes, laboratory standards and quality approach
View profile
Embryology laboratory
Meet the Team →
Fertilisation, embryo culture, development assessment, laboratory safety and traceability processes.
View profileTransparent information
What Are the Risks and Limitations of Tandem IVF?
A tandem programme may increase the number of treatment options available within the same schedule, but it also involves more procedures, more complex decisions and risks from two separate treatment pathways.
Low or absent ovarian response
Despite ovarian stimulation, no oocytes may be obtained from the patient or no mature oocytes may be collected.
Oocyte collection and OHSS risk
The patient has IVF-related risks including pain, bleeding, infection and, rarely, ovarian hyperstimulation.
Developmental failure in either group
Fertilisation or blastocyst development is not guaranteed in either the patient or donor-oocyte group.
Complexity of identity and consent
Managing two separate embryo groups requires clear written consent and robust traceability.
Psychological and ethical burden
Genetic relationships, donor use and decisions about the future of remaining embryos can be challenging.
Legal requirements that vary by country
Rules concerning donor information, anonymity, consent, storage and the status of the child may vary according to the relevant jurisdiction.
Multiple pregnancy
Transferring more than one embryo increases risks for the pregnant patient and babies; a single-embryo approach is considered in suitable patients.
No guarantee of outcome
Using two oocyte sources does not guarantee implantation, healthy pregnancy or live birth.
Patient questions
Frequently Asked Questions About Tandem IVF
Explore common questions about parallel treatment using the patient’s own and donor oocytes, embryo selection, donor screening, duration, risks and treatment costs.
What is tandem IVF?
Tandem IVF, or a tandem cycle, is a combined treatment approach in which IVF using the patient’s own oocytes is planned alongside a separate donation cycle with a suitable egg donor during the same general treatment period.
Are my own oocytes and donor oocytes mixed in a tandem cycle?
No. Oocytes obtained from the patient and donor are handled through separate identity and culture pathways. Embryos from each source are documented separately, and the transfer decision is made according to consent and the clinical plan.
Who may be suitable for tandem IVF?
It may be considered in patients with very low ovarian reserve, advanced reproductive age, repeated low oocyte yield or poor embryo development who wish to make another attempt using their own oocytes while considering donor oocytes as a backup option.
Is a tandem cycle a standard treatment?
A tandem cycle is not a separately standardised guideline term with an identical definition and protocol in every country. It is a clinical programme name describing IVF using the patient’s own oocytes and egg-donation treatment planned simultaneously or close together.
Are two oocyte collections performed during tandem treatment?
Usually, the ovaries of the patient and donor are stimulated separately and each undergoes a separate oocyte-collection procedure. Procedures may occur on the same day or on nearby dates according to the clinical plan.
How is an egg donor selected?
Donor selection should follow applicable regulations, health screening, infection and genetic assessment, medical suitability and the permitted matching information.
Which embryo is transferred in a tandem cycle?
Embryo development from the patient’s own and donor oocytes is assessed separately. Which embryo group is transferred and when is determined according to patient priorities, consent, embryo development, the medical plan and applicable legal requirements.
What happens to donor-derived embryos if an embryo develops from my own oocytes?
According to prior consent and the clinical plan, suitable embryos created from donor oocytes may be frozen and stored for future use or managed according to another legally permitted option. This should be clarified in writing before treatment begins.
Does tandem IVF guarantee success?
No. Having the possibility of creating embryos from two separate oocyte sources may reduce the risk that treatment ends without an embryo, but it does not guarantee fertilisation, blastocyst development, implantation, pregnancy or live birth.
What is the difference between tandem IVF and egg donation?
In egg donation, embryos are created using donor oocytes. In a tandem cycle, IVF using the patient’s own oocytes and the donor-oocyte programme are planned in parallel, potentially creating two separate embryo groups.
Is ICSI used in tandem IVF?
The fertilisation method is selected according to sperm characteristics, oocyte number and the laboratory plan. In many tandem programmes, the oocyte groups may be fertilised separately using ICSI, but the method is selected individually.
How long does tandem IVF take?
Once initial assessment and donor matching are complete, stimulation and oocyte collection commonly extend over about two weeks. Embryo culture, fresh or frozen transfer and endometrial preparation can lengthen the overall schedule.
Can fresh embryo transfer be performed in a tandem cycle?
If uterine conditions, hormone levels and embryo development are suitable, fresh transfer may be planned. If PGT, OHSS risk, endometrial preparation or logistical factors make this inappropriate, embryos may be frozen for later FET.
Can PGT be performed in a tandem cycle?
When clinically indicated and after appropriate counselling, PGT may be planned for embryos at the blastocyst stage. Records and reports for embryos derived from the patient’s own and donor oocytes should remain separate.
What screening is performed for egg donors in tandem IVF?
Screening varies according to applicable local requirements and may include medical and family history, physical assessment, infection testing, ovarian assessment and appropriate genetic carrier screening.
What are the risks of tandem IVF?
Key considerations include ovarian-stimulation and oocyte-collection risks for the patient, ethical and legal requirements related to donor treatment, possible developmental failure in either embryo group, multiple pregnancy and the possibility that treatment does not result in pregnancy.
How does genetic parentage work in tandem IVF?
If an embryo created from the patient’s own oocyte is transferred, the child has a genetic relationship with the intended mother. If an embryo created from a donor oocyte is transferred, the genetic relationship is with the egg donor; the genetic relationship of the person carrying the pregnancy depends on the oocyte source.
How long do I need to stay in Cyprus for tandem IVF?
Although some monitoring can be completed where you live, the patient’s oocyte-collection date, donor coordination, sperm provision, embryo development and transfer plan affect the required stay. The final schedule should be prepared with the clinic coordinator.
What affects the cost of tandem IVF?
Costs may be affected by the patient’s IVF medication and oocyte collection, donor screening and coordination, donor medication and oocyte collection, ICSI, embryo culture, freezing, storage, PGT and the transfer plan.
Is psychological counselling needed before tandem IVF?
Use of donor gametes involves important decisions about genetic relationships, future disclosure to the child, privacy and family dynamics. Discussion with an experienced counsellor may be helpful for many patients and is recommended in some programmes.
Related information
Treatments Related to Tandem IVF
Explore the patient-oocyte, donor-oocyte, embryo-culture and transfer stages that make up a tandem plan.
A personalised roadmap with two options
Let’s Create a Tandem Plan for Your Own Oocytes and Donor Option
Send your AMH and ultrasound results, previous oocyte-collection and embryo reports, semen assessment and treatment priorities. We can review the possibility of IVF using your own oocytes, the donor programme, embryo management and your travel to Cyprus together.
- Assessment of ovarian reserve and previous IVF outcomes
- Donor screening, matching and two separate embryo plans
- International patient, treatment and travel coordination
Medical sources
A tandem cycle is not a separately standardised treatment name in every international guideline. The donor-screening, recipient-assessment, informed-consent, embryo-transfer and laboratory-safety principles described here are supported by current professional guidance.